Fluorescent nanoprobes dedicated to in vivo imaging: from preclinical validations to clinical translation

Molecules. 2012 May 10;17(5):5564-91. doi: 10.3390/molecules17055564.

Abstract

With the fast development, in the last ten years, of a large choice of set-ups dedicated to routine in vivo measurements in rodents, fluorescence imaging techniques are becoming essential tools in preclinical studies. Human clinical uses for diagnostic and image-guided surgery are also emerging. In comparison to low-molecular weight organic dyes, the use of fluorescent nanoprobes can improve both the signal sensitivity (better in vivo optical properties) and the fluorescence biodistribution (passive "nano" uptake in tumours for instance). A wide range of fluorescent nanoprobes have been designed and tested in preclinical studies for the last few years. They will be reviewed and discussed considering the obstacles that need to be overcome for their potential everyday use in clinics. The conjugation of fluorescence imaging with the benefits of nanotechnology should open the way to new medical applications in the near future.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Diagnostic Imaging / instrumentation
  • Diagnostic Imaging / methods*
  • Fluorescence
  • Fluorescent Dyes* / chemistry
  • Humans
  • Molecular Probes* / chemistry
  • Nanoparticles* / chemistry
  • Neoplasms / diagnosis*
  • Neoplasms / surgery
  • Quantum Dots
  • Spectroscopy, Near-Infrared
  • Surgery, Computer-Assisted
  • Tissue Distribution
  • Translational Medical Research

Substances

  • Fluorescent Dyes
  • Molecular Probes